Surgical treatment of oligometastatic non-small cell lung cancer.
about
Clinical outcomes of cytoreductive surgery combined with intrapleural perfusion of hyperthermic chemotherapy in advanced lung adenocarcinoma with pleural disseminationThe lung adenocarcinoma guidelines: what to be considered by surgeons.Unique metastases of ALK mutated lung cancer activated to the adnexa of the uterus.Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancerCombined robotic lobectomy and adrenalectomy for lung cancer and solitary adrenal metastasis.[Consolidative local therapy in oligometastatic NSCLC without progression after first-line chemotherapy].Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors.Surgical Treatment of Extrapulmonary Oligometastatic Non-small Cell Lung Cancer.Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.Effect of synchronous solitary bone metastasectomy and lung cancer resection on non-small cell lung cancer patients.Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: initial survival, local control, and cost observations.Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosisSurgical treatment in non-small cell lung cancer with pulmonary oligometastasisMolecular determinants of lung cancer metastasis to the central nervous system.Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.The evolving role of radiotherapy in treatment of oligometastatic NSCLC.Pooled analysis for surgical treatment for isolated adrenal metastasis and non-small cell lung cancer.Oligometastatic disease at presentation or recurrence for nonsmall cell lung cancer.Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.Survival outcomes for oligometastasis in resected non-small cell lung cancer.Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival†.Stage IV lung cancer: Is cure possible?Radiotherapy for Oligometastatic Lung Cancer.Surgical Management of Non-small Cell Lung Cancer with Solitary Hematogenous Metastases.Application of conditional probability analysis to distant metastases from lung cancer.Oligometastatic non-small cell lung cancer: is there a role for locoregional therapy?Radical local therapy in combination with standard treatment for oligometastatic stage IV non-small-cell lung cancer.Which metastasis management allows long-term survival of synchronous solitary M1b non-small cell lung cancer?Exhaustive preoperative staging increases survival in resected adrenal oligometastatic non-small-cell lung cancer: a multicentre study.[The conceptual oligometastatic non-small cell lung cancer and therapeutic strategies].Exploring the microRNA profiles as potential diagnostic probes for oligo- and polymetastatic prognosis of lung metastasis(es) patients.Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P2860
Q26779613-9003613A-B71B-44F9-A197-57910DDF6EA0Q34404201-E2F1DE93-1922-4168-A202-9F69C96279E6Q34762422-8FA354A8-792A-4324-91FF-3EC15F43B30BQ35121736-BEBF8B8E-F3C6-4EA2-89D2-3F3A30DA5B2BQ36124503-77BB19C6-16A0-49C1-9D5E-FA4E7D4B19A5Q36290582-642DDB17-0E16-4DF8-87FB-D9621B6CDEBDQ36385329-66EE2742-A9C1-4C39-B93C-A5BD39BF7307Q36408553-EF5E085D-662C-40DC-BB98-2E9E6661EE06Q36422709-81B4B4B5-3B6E-40B6-96B9-352D5C0AB444Q36640853-9AD404C0-3FC1-44A7-941D-18BB2750EDB7Q37206054-1DBDB445-52BB-47BA-8640-B54309D8DDE9Q37574059-24449D31-1A6D-4B36-9FC2-B2B670C5202BQ37620819-9F1B1392-AC66-4E16-914F-406C6FD75CFDQ38390049-BAEEF371-7078-49BF-BCBA-D0F1EE40788FQ38409259-D1CED7AA-BA9E-4B7E-A4CB-6E91320BFF15Q38625125-F847EA5F-893D-4E04-9EC5-63055BC24CCCQ38963527-8886F0F7-8CB6-42C4-908C-F72EF0FB55BAQ39567988-2DE24847-C013-4D69-9C30-CF01365610ECQ39697732-25164E81-B2D0-4371-B214-21C52A0F3661Q40700961-9F96317A-117B-4D87-95AA-FA323A22E686Q41504138-EF9D05CF-A905-474E-AC00-17CCE78E5EA3Q41557929-3B6C019C-3F24-4623-B6D6-2272AACE3182Q41895484-A8D1AA35-398D-47F0-B0CF-12DC1AAF50EAQ42109226-FB51A3E7-22F6-46D3-9013-10ECE9965FB7Q42153889-B531F14B-770A-4DE5-9726-56C7A1DF46F2Q42180705-28C54E63-1E7E-4676-8015-5175245171C4Q42342016-1622E5AF-4D75-41E7-B3A3-EB93BAD0E4FBQ42359755-2507333D-B175-4F3C-A468-E03B1C2DB8F9Q48724997-EAD77484-327E-4AF7-A58B-B984EED3C86DQ50204641-86E6F87A-2D37-4842-B478-A5C1641AE2E8Q53271314-9DCD7C2E-5918-4D5D-B628-66CB1DC79026Q55260540-3D44AF8A-1F8E-4AA1-B92A-4ED0E98AE86EQ59274003-5F7C08C4-B2A9-4D77-BFF2-8EC555FA15EE
P2860
Surgical treatment of oligometastatic non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Surgical treatment of oligometastatic non-small cell lung cancer.
@en
Surgical treatment of oligometastatic non-small cell lung cancer.
@nl
type
label
Surgical treatment of oligometastatic non-small cell lung cancer.
@en
Surgical treatment of oligometastatic non-small cell lung cancer.
@nl
prefLabel
Surgical treatment of oligometastatic non-small cell lung cancer.
@en
Surgical treatment of oligometastatic non-small cell lung cancer.
@nl
P1433
P1476
Surgical treatment of oligometastatic non-small cell lung cancer
@en
P2093
Hendrik Dienemann
P304
P356
10.1016/J.LUNGCAN.2010.05.003
P577
2010-09-01T00:00:00Z